The Biden Team Must Prioritize Cheap Rapid Test Production And Distribution

All of us hope that a Covid-19 vaccine will bring an end to our current suffering. But even in the best-case scenario, by the time a vaccine is widely available, hundreds of thousands more lives will be lost. We must use the tools at our disposal to control the virus. Rapid antigen tests could make a difference, but we need much more of them. Mass producing these tests and distributing them to all in need should be the first task of the Biden Covid-19 Task Force and eventual administration.

Since the start of the pandemic, the United States has administered far fewer tests than necessary. A testing tracker developed by the Harvard Global Health Institute suggests that the United States is administering barely more than half the tests we need. Current testing regimes and test supplies are simply not good enough. Most of these early tests took days or even weeks to deliver results, possibly allowing the patient to spread the virus in that time if they were positive. 

Read the full article on Forbes.

© William A. Haseltine, PhD. All Rights Reserved.